The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy in recurrent ovarian cancer: Final overall and progression-free survival results from the AGO-OVAR 2.29/ENGOT-ov34 study.
 
Frederik Marmé
Honoraria - AGENDIA; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Genomic Health; Gilead Sciences; GlaxoSmithKline; Immunomedics (Inst); Lilly; MSD Oncology; Myriad Genetics; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche/Genentech; Seagen
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Clovis Oncology; CureVac; Eisai; Genomic Health; Gilead Sciences; GlaxoSmithKline; Immunomedics (Inst); Pfizer; Roche (Inst); Seagen; Seagen; Vaccibody (Inst)
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Tesaro (Inst); Vaccibody (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Pfizer; Roche
 
Philipp Harter
Honoraria - Amgen; AstraZeneca; Clovis Oncology; Eisai; Exscientia; GlaxoSmithKline; Lilly; Mersana; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; Exscientia; GlaxoSmithKline; Immunogen; Merck; Mersana; Miltenyi Biomedicine; MSD Oncology; Novartis; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Andres Redondo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; MSD
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; MSD
Travel, Accommodations, Expenses - AstraZeneca
 
Alexander Reuss
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; AGENUS; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Daiichi Sankyo; DECIPHERA; Genmab; GlaxoSmithKline; IMMUNOCORE; Immunogen; Macrogenics; MERSANA; MSD Oncology; Novartis; OxOnc; Pfizer; PharmaMar; PMV Pharma; Roche; Seagen; Sutro Biopharma; Tesaro
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; Blueprint Medicines; BMS; Bristol-Myers Squibb; Clovis Oncology; Daichi; Deciphera; Eisai; Genmab; GlaxoSmithKline; Immunocore; Immunogen; Macrogenics; Mersana; MSD Oncology; Novartis; Novocure; Ose pharma; Pfizer; PharmaMar; Roche; Seagen; Sutro Biopharma; Tesaro
Research Funding - BMS; MSD Oncology; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; Belgium health authorities; French National Cancer Institute (INCA); GERMAN health authorities; ITALIAN HEALTH AUTORITIES
 
Kristina Lindemann
Consulting or Advisory Role - AstraZeneca (Inst); Eisai (Inst); GlaxoSmithKline (Inst); MSD (Inst); Nykode Therapeutics (Inst)
Speakers' Bureau - Eisai
Research Funding - GlaxoSmithKline (Inst)
 
Christian Kurzeder
Honoraria - AstraZeneca (Inst); Eli Lilly S.A. (Inst); Genomic Health (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo (Inst); Eli Lilly S.A. (Inst); Genomic Health (Inst); GlaxoSmithKline (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Expert Testimony - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; PharmaMar; Roche
 
Els Van Nieuwenhuysen
Consulting or Advisory Role - AstraZeneca (Inst); Oncoinvent; Regeneron (Inst)
Research Funding - AstraZeneca (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oncoinvent (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Regeneron (Inst)
 
Charlotte Bellier
No Relationships to Disclose
 
Klaus Pietzner
Honoraria - AstraZeneca; Novartis; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Novartis; Tesaro/GSK
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro/GSK
 
Ahmed El-Balat
Honoraria - AstraZeneca; Olympus
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Olympus; Roche
 
Carmen García-Duran
Speakers' Bureau - AstraZeneca Spain; GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Clovis Oncology GmbH; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology GmbH; Eisai Germany; Eisai Germany; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche Pharma AG; Tesaro; Teva
Travel, Accommodations, Expenses - Roche Pharma AG
 
Jose Alejandro Perez-Fidalgo
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline
Speakers' Bureau - AstraZeneca Spain; Clovis Oncology; Eisai; GlaxoSmithKline; MSD Oncology; PharmaMar; Seagen
Research Funding - AstraZeneca Spain (Inst); GlaxoSmithKline (Inst); Pharmamar (Inst)
Patents, Royalties, Other Intellectual Property - Pending patent
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca Spain; Novartis
 
Frederic Selle
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline/Tesaro; MSD; Seagen
Consulting or Advisory Role - Abbvie; AstraZeneca; GlaxoSmithKline/Tesaro; MSD
Speakers' Bureau - AstraZeneca; Eisai; GlaxoSmithKline/Tesaro; MSD
 
Nikolaus de Gregorio
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai Germany; Gilead Sciences; GlaxoSmithKline; MSD; Myriad Genetics; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Alexander Burges
Speakers' Bureau - AstraZeneca; Roche; Tesaro
 
Ignacio Romero
Consulting or Advisory Role - AstraZeneca Spain; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; PharmaMar; Roche
Research Funding - GlaxoSmithKline (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
 
Annette Hasenburg
Honoraria - AstraZeneca; Celgene; GlaxoSmithKline; LEO Pharma; MedConcept; Medicultus Kassel; Pfizer; Promedicis ; Roche; SoftConsultGroup; Streamedup!; Tesaro
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/MSD; LEO Pharma; PharmaMar; Promedicis; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; MedConcept
 
Patricia Pautier
Consulting or Advisory Role - AstraZeneca (Inst); MSD Oncology (Inst); MSD vaccin (Inst); Onxeo (Inst); PharmaMar (Inst); Seagen
Research Funding - Onxeo (Inst); PharmaMar (Inst)
Expert Testimony - GlaxoSmithKline (Inst); Onxeo (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; GlaxoSmithKline; MSD Oncology; OSE Immunotherapeutics; PharmaMar
Other Relationship - PharmaMar